DOI: 10.1002/chem.201503176
Communication
&
Bioinorganic Chemistry
To Transfer or Not to Transfer? Development of a Dinitrosyl Iron
III
Complex as a Nitroxyl Donor for the Nitroxylation of an Fe –
Porphyrin Center
[a]
[b]
[a]
[a]
[a]
Yu-Ting Tseng, Chien-Hong Chen, Jing-Yu Lin, Bing-Han Li, Yu-Huan Lu, Chia-
[a]
[a]
[c]
[c]
[d]
Her Lin, Hsin-Tsung Chen, Tsu-Chien Weng, Dimosthenes Sokaras, Huang-Yeh Chen,
[
d, e]
[a]
Yun-Liang Soo,
and Tsai-Te Lu*
opment of an exogenous nitroxyl donor as a novel approach
[
4–7]
for the acute treatment of heart failure.
Angeli’s salt
Abstract: A positive myocardial inotropic effect achieved
using HNO/NO , compared with NO·, triggered attempts
À
(Na N O ) and Piloty’s acid (PhSO NHOH) were predominantly
2
2
3
2
exploited as nitroxyl-releasing reagents at neutral and basic
pH, respectively, to explore the vascular and myocardial phar-
to explore novel nitroxyl donors for use in clinical applica-
tions in vascular and myocardial pharmacology. To devel-
op M-NO complexes for nitroxyl chemistry and biology,
modulation of direct nitroxyl-transfer reactivity of dinitro-
syl iron complexes (DNICs) is investigated in this study
À
macology of HNO/NO . Rapid decomposition of Angeli’s salt
À4 À1
À3 À1
(
k=610
s
at 258C and k=4–510
s
at 378C), rapid
6
À1 À1
dimerization of HNO to afford N O and H O (k=810 m s ),
2
2
III
and release of NO rather than nitroxyl from Piloty’s acid under
neutral aerobic conditions, however, limit the clinical potential
using a Fe -porphyrin complex and proteins as a specific
9
Me
probe. Stable dinuclear {Fe(NO) } DNIC [Fe(m- Pyr)(NO) ]
2
2 2
[
7]
of these compounds. As a consequence, a long-lasting HNO/
was discovered as a potent nitroxyl donor for nitroxylation
À
III
NO donor derived from steady nitroxyl-releasing compounds
of Fe -heme centers through an associative mechanism.
with an ON/OFF switch or from stable compounds with dedi-
Beyond the efficient nitroxyl transfer, transformation of
DNICs into a chemical biology probe for nitroxyl and for
pharmaceutical applications demands further efforts using
in vitro/in vivo studies.
III
cated nitroxyl-transfer reactivity toward the Fe center in heme
proteins is a much-needed target for pharmaceutical applica-
tions.
The intrinsic redox propensity of transition metals in metal–
nitrosyl complexes modulates the oxidation state of NO and
allows the potential use of MÀNO complexes in nitroxyl
n
À
[8–13]
HNO/NO (nitroxyl), compared to NO·, features a specific bio-
chemistry.
In particular, the electronic structure of {M(NO) }
x
III
logical reactivity in the nitroxylation of Fe -heme centers and
complexes (M=Fe or Co, x=1 or 2, n=7, 8, 9, or 10) regulates
III
modification of thiol residue in cysteine to sulfonamide/disul-
fide, in addition to the up-regulation of plasma levels of calci-
the redox switch for the reductive nitrosylation of the Fe -por-
phyrin complex/protein and controls the proton-induced ni-
[1–3]
[14–19]
9
10
tonin gene-related peptide (CGRP).
Moreover, a positive my-
troxyl-release reactivity.
{Fe(NO) } /{Fe(NO) } complexes
2 2
0
/1À
ocardial inotropic effect of nitroxyl, during a congestive heart
failure condition in particular, stimulated the study of a mecha-
nism for the endogenous generation of nitroxyl and the devel-
[Fe(NO) (Ar-nacnac)]
exhibit an electrochemically reversible
2
redox couple at À1.34 V, whereas the reduction potential for
III
+
[Fe (TPP)Cl] is À0.90 V versus Fc/Fc (Ar-nacnac = anion of
[
14,20]
[
(2,6-diisopropylphenyl)NC(Me)] CH).
In contrast to the in-
2
[
a] Y.-T. Tseng, J.-Y. Lin, B.-H. Li, Y.-H. Lu, Prof. C.-H. Lin, Prof. H.-T. Chen,
Prof. T.-T. Lu
Department of Chemistry, Chung Yuan Christian University No. 200
Chung Pei Rd. Taoyuan, 32023 (Taiwan)
E-mail: TTLu@cycu.edu.tw
9
ertness of the {Fe(NO) } complex [Fe(NO) (Ar-nacnac)] toward
2
2
III
III
[
Fe (TPP)Cl], reductive nitrosylation of [Fe (TPP)Cl] by
10
À
{Fe(NO)2} [Fe(NO) (Ar-nacnac)] to afford [Fe(TPP)(NO)] occurs
2
through a redox-coupled nitrosyl transfer pathway according
II
À
9
[
b] Prof. C.-H. Chen
to the formation of intermediates [Fe (TPP)Cl] and {Fe(NO)2}
Fe(NO) (Ar-nacnac)]. Harrop and co-workers reported a ther-
School of Medical Applied Chemistry, Chung Shan Medical University
No. 110, Section 1, Jianguo North Rd. Taichung, 40201 (Taiwan)
[
2
8
À
mally stable {Fe(NO)} complex [Fe(LN )(NO)] with a E1/2 of
4
[
c] Dr. T.-C. Weng, Dr. D. Sokaras
SLAC National Accelerator Laboratory 2575 Sand Hill Rd. Menlo Park
CA 94025 (USA)
7
8
[15]
À1.38 V for a {Fe(NO)} /{Fe(NO)} redox couple. A redox-cou-
pled nitrosyl-transfer mechanism was followed using this
8
À
[
d] H.-Y. Chen, Prof. Y.-L. Soo
{Fe(NO)} complex [Fe(LN )(NO)] to achieve the rapid conver-
4
National Synchrotron Radiation Research Center No. 101, Xin’an Rd.
Hsinchu, 30076 (Taiwan)
sion of metmyoglobin (metMb) to MbNO in aqueous buffer so-
lution at pH 7.2. Of interest, replacement of iron by cobalt to
[
e] Prof. Y.-L. Soo
Department of Physics, National Tsing Hua University No. 101
Section 2, Guangfu Rd., Hsinchu, 30013 (Taiwan)
8
afford the {Co(NO)} complex [Co(LN )(NO)] leads to an irrever-
4
sible Eox peak at 0.75 V and abolishes the reductive nitrosyla-
[
16]
tion reactivity. The release of HNO from this complex was
[
16]
promoted after addition of 1 equiv of HBF4. This proton-in-
Chem. Eur. J. 2015, 21, 17570 – 17573
17570
ꢀ 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim